0.307
price up icon0.13%   0.0004
after-market Handel nachbörslich: .31 0.003 +0.98%
loading
Schlusskurs vom Vortag:
$0.3066
Offen:
$0.31
24-Stunden-Volumen:
591.50K
Relative Volume:
0.60
Marktkapitalisierung:
$8.32M
Einnahmen:
$598.00K
Nettoeinkommen (Verlust:
$-44.93M
KGV:
-0.0369
EPS:
-8.31
Netto-Cashflow:
$-17.32M
1W Leistung:
+3.02%
1M Leistung:
-54.85%
6M Leistung:
-75.54%
1J Leistung:
-92.82%
1-Tages-Spanne:
Value
$0.294
$0.33
1-Wochen-Bereich:
Value
$0.2754
$0.33
52-Wochen-Spanne:
Value
$0.2682
$4.50

Ernexa Therapeutics Inc Stock (ERNA) Company Profile

Name
Firmenname
Ernexa Therapeutics Inc
Name
Telefon
(617) 798-6700
Name
Adresse
1035 CAMBRIDGE STREET, CAMBRIDGE
Name
Mitarbeiter
6
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
ERNA's Discussions on Twitter

Compare ERNA vs VRTX, REGN, ARGX, ALNY, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ERNA
Ernexa Therapeutics Inc
0.307 8.30M 598.00K -44.93M -17.32M -8.31
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.82 121.40B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
764.93 83.25B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
728.11 46.39B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.51 43.41B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
292.94 33.09B 5.36B 287.73M 924.18M 2.5229

Ernexa Therapeutics Inc Aktie (ERNA) Neueste Nachrichten

pulisher
Mar 04, 2026

Ernexa Therapeutics Inc.Common Stock (NQ: ERNA - FinancialContent

Mar 04, 2026
pulisher
Mar 04, 2026

Comparing Aditxt (NASDAQ:ADTX) & Ernexa Therapeutics (NASDAQ:ERNA) - Defense World

Mar 04, 2026
pulisher
Feb 27, 2026

ERNA Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 27, 2026
pulisher
Feb 26, 2026

Eterna Therapeutics Updates Investor Presentation, Highlights Web Disclosure - TipRanks

Feb 26, 2026
pulisher
Feb 26, 2026

Ernexa Therapeutics updates investor presentation, posts Exhibit 99.1 on website - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Ernexa Therapeutics (NASDAQ: ERNA) furnishes new February 2026 investor presentation - Stock Titan

Feb 26, 2026
pulisher
Feb 24, 2026

Ernexa Therapeutics (NASDAQ:ERNA) Trading Down 11.4% – Time to Sell? - Defense World

Feb 24, 2026
pulisher
Feb 20, 2026

Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series - GlobeNewswire

Feb 20, 2026
pulisher
Feb 20, 2026

Will Ernexa Therapeutics Inc. stock outperform value stocksQuarterly Growth Report & Fast Moving Stock Watchlists - mfd.ru

Feb 20, 2026
pulisher
Feb 18, 2026

Insider Stock Purchases: February 18, 2026 - Quiver Quantitative

Feb 18, 2026
pulisher
Feb 17, 2026

Ernexa therapeutics ten percent owner Cherington buys $2m in stock By Investing.com - Investing.com India

Feb 17, 2026
pulisher
Feb 17, 2026

Ernexa therapeutics ten percent owner Cherington buys $2m in stock - Investing.com

Feb 17, 2026
pulisher
Feb 16, 2026

ERNA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 16, 2026
pulisher
Feb 16, 2026

Will Ernexa Therapeutics Inc. outperform tech stocksJuly 2025 Chart Watch & Accurate Buy Signal Notifications - mfd.ru

Feb 16, 2026
pulisher
Feb 16, 2026

Can Ernexa Therapeutics Inc. continue delivering strong returnsQuarterly Trade Review & Capital Efficiency Focused Strategies - mfd.ru

Feb 16, 2026
pulisher
Feb 14, 2026

Will Ernexa Therapeutics Inc. stock remain a Wall Street favoriteWeekly Market Outlook & Short-Term High Return Ideas - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

Aug Shorts: Is Ernexa Therapeutics Inc a strong candidate for buy and holdTreasury Yields & Proven Capital Preservation Methods - baoquankhu1.vn

Feb 13, 2026
pulisher
Feb 12, 2026

Will Ernexa Therapeutics Inc. stock benefit from green energy trendsTrade Volume Summary & Accurate Buy Signal Notifications - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

Eterna Therapeutics Completes Public Offering to Bolster Capital - TipRanks

Feb 11, 2026
pulisher
Feb 11, 2026

Ernexa Therapeutics Signs Multiple Financing Agreements - TradingView

Feb 11, 2026
pulisher
Feb 11, 2026

Profit Review: Can Ernexa Therapeutics Inc. be recession proofWeekly Gains Report & Daily Momentum Trading Reports - mfd.ru

Feb 11, 2026
pulisher
Feb 11, 2026

What hedge fund activity signals for Ernexa Therapeutics Inc. stockJuly 2025 PostEarnings & Target Return Focused Picks - mfd.ru

Feb 11, 2026
pulisher
Feb 08, 2026

Total debt of Ernexa Therapeutics Inc. – NASDAQ:ERNAW - TradingView

Feb 08, 2026
pulisher
Feb 06, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Feb 06, 2026
pulisher
Feb 06, 2026

Ernexa Therapeutics prices $10.5 million public offering at $0.50 per share - Investing.com

Feb 06, 2026
pulisher
Feb 06, 2026

Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering - The Manila Times

Feb 06, 2026
pulisher
Feb 06, 2026

Ernexa Therapeutics Inc. Announces Pricing of $10.5 Million Public Offering of Common Stock and Warrants - Quiver Quantitative

Feb 06, 2026
pulisher
Feb 06, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Feb 06, 2026
pulisher
Feb 05, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Feb 05, 2026
pulisher
Feb 05, 2026

Street Watch: Is Ernexa Therapeutics Inc forming bullish engulfing patternsQuarterly Investment Review & Reliable Entry Point Alerts - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 04, 2026

Valuation Update: Why is Ernexa Therapeutics Inc stock going up2025 Volume Leaders & Proven Capital Preservation Methods - baoquankhu1.vn

Feb 04, 2026
pulisher
Feb 03, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Feb 03, 2026
pulisher
Feb 03, 2026

Ernexa Therapeutics Advances toward First-in-Human Trial for Ovarian Cancer Following Successful Pre-IND Meeting with FDA - Quiver Quantitative

Feb 03, 2026
pulisher
Feb 03, 2026

Ernexa Therapeutics Participates in Virtual Investor “What - GlobeNewswire

Feb 03, 2026
pulisher
Jan 27, 2026

Japanese trade program selects Ernexa Therapeutics among elite biotech group - Investing.com Canada

Jan 27, 2026
pulisher
Jan 27, 2026

Ernexa Therapeutics Selected for Japan Entry Acceleration Program to Advance Innovative Cell Therapies - Quiver Quantitative

Jan 27, 2026
pulisher
Jan 27, 2026

Ernexa Therapeutics Selected as One of Only Ten Global - GlobeNewswire

Jan 27, 2026
pulisher
Jan 27, 2026

Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program - Yahoo Finance

Jan 27, 2026
pulisher
Jan 25, 2026

New Highs: Can Ernexa Therapeutics Inc be recession proofEarnings Overview Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 21, 2026

Can Ernexa Therapeutics Inc. be recession proofJuly 2025 News Drivers & Low Risk Entry Point Guides - baoquankhu1.vn

Jan 21, 2026
pulisher
Jan 20, 2026

Top movers in Tuesday's after hours session - ChartMill

Jan 20, 2026
pulisher
Jan 18, 2026

Breakout Zone: Is RICK showing insider buyingRisk Management & Growth Focused Investment Plans - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 18, 2026

Update Report: Is Ernexa Therapeutics Inc forming bullish engulfing patternsEarnings Recap Summary & Long Hold Capital Preservation Plans - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 17, 2026

Can Ernexa Therapeutics Inc continue delivering strong returnsPortfolio Gains Report & Reliable Intraday Trade Plans - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 16, 2026

Volume Report: What is TTGTs revenue forecastTrade Risk Report & Long-Term Safe Investment Ideas - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 15, 2026

Ernexa Therapeutics (NASDAQ:ERNA) vs. Inotiv (NASDAQ:NOTV) Critical Review - Defense World

Jan 15, 2026
pulisher
Jan 14, 2026

Market Recap: Can Ernexa Therapeutics Inc continue delivering strong returnsJuly 2025 PostEarnings & Low Risk High Reward Ideas - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 13, 2026

Aug PostEarnings: Will Ernexa Therapeutics Inc. stock recover faster than peersMarket Performance Report & Weekly Top Performers Watchlists - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Bull Run: How institutional buying supports Ernexa Therapeutics Inc stockJuly 2025 Trends & Low Drawdown Momentum Trade Ideas - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 08, 2026

Is Ernexa Therapeutics Inc. stock trading at a premium valuationJuly 2025 Pullbacks & Technical Pattern Alert System - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

How Ernexa Therapeutics Inc. stock reacts to inflationary pressures2025 Price Momentum & Daily Price Action Insights - Улправда

Jan 08, 2026

Finanzdaten der Ernexa Therapeutics Inc-Aktie (ERNA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ernexa Therapeutics Inc-Aktie (ERNA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Cherington Charles
10% Owner
Jun 09 '25
Buy
0.10
21,241,163
2,221,826
41,659,743
Cherington Charles
10% Owner
Apr 02 '25
Buy
0.10
3,768,397
394,174
20,401,602
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
Kapitalisierung:     |  Volumen (24h):